Finance

Lists
AMBBY:OTCMKTS
Ambu AS Unsponsored Denmark ADR
11,00 USD
0,00%
(0,00) 1D
30-сен., 09:30:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AMBBY...
Mkt. cap
17,12 млд
Avg. vol.
91,00
Volume
2,00
52-wk high
16,31 USD
52-wk low
9,38 USD
Beta
1,42
Shares outstanding
234,97 млн
No. of employees
5 миң
Mkt. cap
17,12 млд
Avg. vol.
91,00
Volume
2,00
52-wk high
16,31 USD
52-wk low
9,38 USD
Beta
1,42
Shares outstanding
234,97 млн
No. of employees
5 миң
News stories
From web sources and news partners
Profile
Ambu, or officially Ambu A/S, is a Danish company that develops, produces and markets single-use endoscopy solutions, diagnostic and life-supporting equipment to hospitals, private practices, and rescue services. It was founded in Denmark in 1937, as Testa Laboratorium, by German engineer Holger Hesse. The largest business areas are anesthesia, cardiology, neurology, pulmonology, urology and gastroenterology. The company's most important products are devices for artificial ventilation, single-use endoscopes and single-use electrodes for ECG tests and neurophysiological mappings. Wikipedia
About Ambu AS Unsponsored Denmark ADR
CEOBritt Meelby Jensen
Employees5,2 миң
Founded1937
Headquarters-
SectorMedical device
Websiteambu.com
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,47 млд
1,56 млд
1,57 млд
1,64 млд
Cost of goods sold
587,00 млн
611,00 млн
625,00 млн
665,00 млн
Cost of revenue
587,00 млн
611,00 млн
625,00 млн
665,00 млн
Research and development expenses
93,00 млн
94,00 млн
91,00 млн
87,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
639,00 млн
689,00 млн
684,00 млн
667,00 млн
Operating expense
732,00 млн
783,00 млн
775,00 млн
754,00 млн
Total operating expenses
1,32 млд
1,39 млд
1,40 млд
1,42 млд
Operating income
147,00 млн
164,00 млн
173,00 млн
221,00 млн
Other non operating income
-
-
-
-
EBT including unusual items
150,00 млн
153,00 млн
157,00 млн
203,00 млн
EBT excluding unusual items
150,00 млн
153,00 млн
157,00 млн
203,00 млн
Income tax expense
35,00 млн
35,00 млн
36,00 млн
47,00 млн
Effective tax rate
23,33%
22,88%
22,93%
23,15%
Other operating expenses
-
-
-
-
Net income
115,00 млн
118,00 млн
121,00 млн
156,00 млн
Net profit margin
7,84%
7,57%
7,69%
9,51%
Earnings per share
0,43
0,44
0,46
0,59
Interest and investment income
17,00 млн
4,00 млн
3,00 млн
6,00 млн
Interest expense
-
-15,00 млн
-19,00 млн
-24,00 млн
Net interest expenses
17,00 млн
-11,00 млн
-16,00 млн
-18,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
183,00 млн
261,00 млн
271,00 млн
321,00 млн
Gain or loss from assets sale
2,00 млн
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору